Dr Mansukh Mandaviya reviews status of essential medicines with Pharma Companies
The pharma companies were asked to keep a close watch on the global supply chain scenario.
New Delhi: Union Minister of Health & Family Welfare and Chemicals & Fertilizers, Dr. Mansukh Mandaviya reviewed the status, adequacy of COVID management drugs and production capacities with representatives of pharma companies through a VC, so that India is equipped to effectively handle any situation. This review meeting was taken in view of the spike in COVID-19 cases in some countries worldwide.
The pharma companies were asked to keep a close watch on the global supply chain scenario. They were also asked to closely monitor production and availability of APIs as well as formulations of essential medicines for COVID management. They were asked to ensure adequate stocks and availability of all drugs including COVID drugs in the supply chain up to the retail level.
Read also: Dr Mansukh Mandaviya inaugurates new building of CDSCO Bhawan, South Zone in Chennai
The pharma companies hailed the timely review meeting chaired by the Union Minister and assured their continued support. They expressed confidence that they will be able to manage the supply chain of COVID drugs.
Shri Rajesh Bhushan, Union Health Secretary, Ms. S Aparna, Secretary (Pharma), Shri Kamlesh Pant, Chairman, NPPA, Dr V G Somani, DCGI, and representatives from pharmaceutical companies were present during the review meeting.
